Arrowhead Pharmaceuticals, Inc. (ARWR) stock analysis

ARWR · Arrowhead Pharmaceuticals, Inc.

Latest recorded price: USD 42.99

Sector and industry: Healthcare · Biotechnology

Fiscal 2026 figures: revenue growth 23.3%, free cash flow margin -63.0%. The model flags 3 risk signals for this company (2 high severity).

Similar companies in Healthcare